Medicine & Health

Sarah Ackerman, an assistant professor of pathology and immunology at the School of Medicine, has received a 2023 Klingenstein-Simons Fellowship Award in Neuroscience.

Research from mechanical engineers Ruth Okamoto and Philip Bayly at the McKelvey School of Engineering finds that the brain’s vulnerability to head motion depends on the direction and frequency, not just impact strength.

With support from a $3 million grant from the National Institutes of Health (NIH), a multidisciplinary team led by Hong Chen at the McKelvey School of Engineering seeks to integrate ultrasound with genetics to precisely modify neurons in the brain.

A study by researchers at the School of Medicine reveals that household and community poverty may influence brain health in children. Childhood obesity and lower cognitive function may explain, at least partially, poverty’s influence on the brain.

Washington University researchers found that how children’s brains process emotional cues typically is set by the time they are school age. They studied brain scans from hundreds of children ages 5 to 15 who watched videos that dealt with emotional topics.

Wearable brain-imaging tech aims to reveal how the brain works in natural, realistic situations. Washington University researchers received a National Institutes of Health (NIH) grant to develop and commercialize a brain-imaging cap that uses LED light to gauge brain activity.

Researchers at the McKelvey School of Engineering discovered how to use focused ultrasound with microbubbles to examine the glymphatic system. Impairments in this system may contribute to brain diseases, such as neurodegenerative diseases and stroke.

Paul Taghert, a professor of neuroscience at the School of Medicine, received an Outstanding Investigator Award of nearly $2 million from the National Institutes of General Medical Sciences to study how the circadian clock orchestrates multiple biological cycles that operate at different phases.

A new drug has been approved by the Food and Drug Administration (FDA) for a rare, inherited form of amyotrophic lateral sclerosis (ALS). The drug — based in part on research conducted at the School of Medicine — slows the progression of the deadly, paralyzing disease.

A new study by researchers at the School of Medicine reveals that a connection between the body and mind is built into the structure of the brain.